Abstract: The purpose of this study was to de®ne the incidence and type of pulmonary complications experienced by children after orthotopic liver transplantation (OLT). The radiological records of all patients receiving OLT during a 3-yr period were reviewed to identify evidence of a pulmonary abnormality. Medical records were then reviewed to determine type, duration, therapy and outcome of pulmonary disorders. Potential risk factors for the development of persistent pleural effusions were also analyzed. One hundred and ®fty-one pediatric liver transplantations were performed on 113 patients during this period. Pneumonia developed in 27 patients, including 11 proven bacterial, six presumed bacterial, six viral and four fungal cases. All three deaths related to pulmonary complications were in this group. Three patients developed mild pulmonary hemorrhages, and three developed pulmonary calci®cations, which did not impair lung function. Sixteen patients developed paralysis of the right hemidiaphragm, four required diaphragm plication. Pleural effusions developed in 86 patients, 38 persisted longer than 7 days. Patients with persistent effusions were more likely to develop allograft rejection than patients with no persistent effusion (p , 0.01) by x 2 analysis. Seven patients required tracheostomy placement. Of these, four were successfully decannulated, two died from non-pulmonary complications and one is receiving home ventilator support. In conclusion, the majority of children experience at least one pulmonary complication after OLT, but mortality due to pulmonary disease is low in this population. Persistent pleural effusions may be a heralding sign of allograft rejection. Viral, bacterial and fungal pneumonia were the only pulmonary causes of death and only one patient in this series has had signi®cant chronic lung disease.
OLT has become the standard of care for many pediatric patients with otherwise fatal liver diseases. One-year survival rates after OLT in children have been reported to be as high as 85±90% (1) . Most post-OLT mortality occurs within 3 months after OLT from complications including hepatic artery and portal vein thrombosis, systemic infection, and allograft rejection. Pulmonary complications have been reported as an important cause of postoperative morbidity and mortality in adult OLT recipients (2±5). The surgical procedure itself, including anesthesia, prolonged retraction of the right hemidiaphragm and¯uid shifts caused by blood loss and replacement, predisposes the patient to atelectasis. Administration of immunosuppression and the need for postoperative mechanical ventilation further contribute to the development of pulmonary problems. In adults, pulmonary infections occur in almost 25% of patients, with opportunistic infections being the most common (3, 5) . Pleural effusions are an almost universal ®nding in patients during the ®rst post-operative week, but few require thoracentesis or chest tube placement (5) .
We have observed these same problems in pediatric liver transplant patients (1) . However, a comprehensive analysis of pulmonary complications in pediatric OLT recipients has never been published. Therefore, we reviewed our experience with pulmonary complications in pediatric liver transplant recipients to better understand the spectrum of post-operative pulmonary disease in this population.
Methods
We examined the computerized radiologic reports of 113 pediatric patients who received 151 liver transplants from 13 July 1992 through 2 August 1995. Since all transplant patients had routine chest X-rays for 2±3 days after the procedure, our assumption was that any pulmonary changes would be picked up even in the absence of clinical disease. It seemed reasonable that any respiratory disease at a later stage would have resulted in some radiologic examination and that the report of that evaluation would contain key words that could be identi®ed by electronic search. There was complete chart review of all patients who had any type of pulmonary complication radiographically. The follow-up time period from the date of transplantation was 2.5±42 months. Any pulmonary complication occurring within the institution of this study was documented. The antibiotic prophylaxis protocol included intravenous ampicillin and cefotaxime for the ®rst 48 h following the transplant. Children less than 4 yrs old received oral bactrim three times per week as prophylaxis against Pneumocystis carinii infection. In addition, intravenous ganciclovir was given for 2 weeks followed by acyclovir orally for 3 months for patients at risk for primary cytomegalovirus infection. The liver transplantation program requires that patients report any fever or respiratory status changes for the ®rst 6 months following initial discharge from the hospital. Patients with signi®cant respiratory distress requiring hospitalization were admitted to the parent institution, including out-of-state transfers. Pulmonary sequelae occurring at an outside institution after this time period were not consistently captured.
The key words in the search included in®ltrate, effusions, pulmonary hemorrhages, diaphragm elevations, and pulmonary calci®cations. Pneumonic in®ltrates were reported as being consistent with either atelectasis or pneumonia. The infectious etiology of any pneumonia was determined by the results of endotracheal tube culture, nasopharyngeal aspirate, lung biopsy or blood culture reported in the patient's medical record. If a positive culture was not obtained, pneumonia was presumed bacterial based on persistence of the pulmonary in®ltrate, the patient's clinical status (i.e. febrile with respiratory distress), and the clinician's decision to administer a course of anti-microbial therapy.
A pleural effusion was de®ned as persistent if it lasted at least 7 days. The results of pleural¯uid analysis from thoracentesis were collected. We searched for factors potentially associated with pleural effusions, including ascites, pneumonia and allograft rejection. Allograft rejection which occurred within 2 weeks of the onset of the effusion was de®ned by characteristic ®ndings from liver biopsy. The incidence of acute allograft rejection in patients with persistent pleural effusions was compared to those without persistent effusions using x 2 analysis. Likewise, pleural uid cell counts obtained from persistent pleural effusions associated with rejection were compared to those which were not associated with rejection.
Post-OLT diaphragm paralysis was identi®ed by new-onset right hemidiaphragm elevation. Frequently, an ultrasound of the diaphragm was performed to con®rm decreased or paradoxical motion.
Therapeutic interventions identi®ed from the radiology records included tracheostomy placement, ECMO, diaphragm plication, and chest tube placement. Chest tube placement during the transplant procedure is routinely performed whenever there is an inadvertent breech of the diaphragm. Chest tubes placed for this reason were not included in this analysis. Medical chart reviews were performed to determine the outcomes of the interventions and to determine whether the cause of a patient's death was related to a pulmonary complication.
Results
One hundred and ®fty-one liver transplants were performed over a three-year period. The majority of the transplants (67%) were reduced segment grafts. The median age at the time of transplant was 1.6 yrs (range 0.7±17.2 yrs.). The overall actuarial patient survival rate was 75%, with a graft survival rate of 75% also. The indications for OLT in this series are shown in Table 1 . Biliary atresia was the most frequent indication, accounting for 48% of recipients. Chronic lung disease prior to transplantation was rare in our population; only two infants had mild bronchopulmonary dysplasia. Patients with cystic ®brosis and a-1 anti-trypsin de®ciency had normal preoperative pulmonary function testing. Clinically signi®cant pulmonary arteriovenous shunting was also not seen in our population prior to transplantation.
The number of documented pulmonary abnormalities and associated sequelae are as follows. Twenty-seven patients (17.8% of all transplant recipients) suffered from pneumonia. Eleven of these were bacterial in origin, six were presumed bacterial, six were viral and six were fungal. The range of onset of pneumonia was from post-operative day 1±128. There was no trend between the type of pneumonia and the time of onset. Table 2 describes the frequency, infectious etiology, time of onset and outcome of the pneumonia. Three children died as a direct result of an infectious pulmonary complication. One infant succumbed to parain¯uenza pneumonia ( Fig. 1 ), another to fulminant aspergillosis, and one died from presumed bacterial pneumonia with cardiopulmonary failure.
Pulmonary hemorrhages were diagnosed by the new onset of moderate amounts of blood suctioned from the endotracheal tube coupled with a new in®ltrative process on the chest X-ray. Three such pulmonary hemorrhages occurred. The hemorrhages were not associated with serious respiratory compromise. However, two of these three patients ultimately died of other causes. Three patients developed pulmonary calci®cations, all of whom had normal calcium metabolism. Respiratory complications were not related to the calci®cations. One patient had persistent pulmonary calci®cations that remained unchanged over a two-year period and were not clinically relevant (Fig. 2) Sixteen transplant recipients (10.6%) suffered from some degree of right diaphragm dysfunction. Most of the patients did not have substantial pulmonary compromise; however, four required diaphragm plication. Diaphragm paralysis leading to inability to adequately mechanically ventilate two patients was the reason for plication within 24 h post-transplant. One of these patients was undergoing her third OLT when plication was performed. She had experienced right diaphragm paralysis for over 3 weeks and had persistent tachypnea and hypoxia. Plication on the other two patients occurred on post-operative days 6 and 12, secondary to dyspnea, tachypnea, and inability to wean off the ventilator.
Pleural effusions were identi®ed in 86 recipients (76%). Approximately half of all effusions began within 48 h after surgery and the time until Pulmonary complications following liver transplant resolution of the effusion was not ascertained. Thirty-eight of the pleural effusions were persistent (25%). Persistent pleural effusions were seen concurrently with ascites in six patients and pneumonia in nine patients. The occurrence of allograft rejection with persistent pleural effusion was 74% (28 of the 38 cases), compared with 47% in those without persistent pleural effusions (53 of 113 cases), p , 0.01 by x 2 analysis. The mean time interval from the transplant date to the start of the persistent pleural effusion was 6 days in the patients with subsequent rejection. Also, 52% of those effusions that were associated with rejection required chest tube placement, compared to 36% of those that did not involve rejection.
Pleural¯uid cell count results were available in 22 patients with persistent pleural effusions. Transplant rejection was present in 17 of these patients, of which 11 (65%) were lymphocytepredominant and six were neutrophil-or macrophage-predominant. Five tapped effusions were not concurrent with rejection; four of these ®ve samples were neutrophil-or macrophage-predominant. There was no statistically signi®cant association between pleural¯uid lymphocyte predominance and rejection.
Therapeutic interventions involving pulmonary complications included chest tube placement, tracheostomy and ECMO. Fifty-®ve per cent of all pleural effusions required chest tube placement to improve respiratory function. There were no chest tubes placed for a pneumothorax or hemothorax.
Seven patients required tracheostomy placement. Five of these were less than 18 months old at the time of placement, and one infant had a pretransplant history of bronchopulmonary dysplasia. The indications for tracheostomy were prolonged ventilation (de®ned as ventilator support for more than 30 consecutive days) in six patients and subglottic stenosis in one. The outcome of these patients is as follows: four were decannulated, two died from non-pulmonary complications, and one remains cannulated and is receiving home ventilator support. The patient who is on a home ventilator had his liver transplantation at 3 months of age. He was born at 32 weeks gestational age and his neonatal course was complicated by bronchopulmonary dysplasia, pulmonary hemorrhage shortly before transplantation, and a grade III intraventricular hemorrhage associated with hydrocephalus. He was intubated for almost 3 months and several attempts to wean off mechanical ventilation were unsuccessful, resulting in tracheal cannulation. The patient's ventilator dependency was felt to be a combination of his previous lung damage and his abnormal neurological status.
ECMO was used as a life-saving tool in three liver transplant recipients. A 9-month-old infant developed severe parain¯uenza pneumonia and died shortly after being placed on ECMO. A 4-month-old patient with RSV pneumonia required ECMO support for 18 days. A 5-month-old with Pseudomonas pneumonia received ECMO for 16 days. Both patients were alive without signi®cant chronic lung disease 2 yrs after ECMO. In this series, 28 deaths (24.8%) occurred after liver transplantation. There were three deaths directly related to pulmonary disease. A 13-yr-old boy with no pre-existing lung disease developed pulmonary aspergillosis on post-operative day 27 following his second liver transplant. He had lost his ®rst graft to rejection and had been on escalated doses of immunosuppression prior to the second transplant. Shortly after the diagnosis of aspergillus was established he developed toxic epidermal necrolysis with desquamation of bronchial tissue and ARDS. The second death occurred in a 9-month-old former preterm infant with a history of bronchopulmonary dysplasia who developed parain¯uenza pneumonia with respiratory failure on post-operative day 15. Finally, a 17-month-old girl died from presumed bacterial pneumonia and cardiopulmonary failure, which occurred on post-operative day 50 following her fourth liver transplant.
Discussion
Pulmonary complications following pediatric OLT in this series accounted for substantial morbidity but little mortality. The majority of transplant recipients suffered from a pulmonary complication; however, only 3% died as a direct consequence. By far the most common complication was pleural effusion. Persistent pleural effusions were often the heralding sign of liver allograft rejection and frequently required chest tube placement for management. Pneumonia was the most important contributing factor to overall morbidity and mortality. Three patients died and one has severe chronic lung disease as a consequence of a post-OLT pulmonary infection.
A major strength of this retrospective study is that not a single patient was excluded ± every transplant recipient had at least two chest X-rays post-operatively. This study does have several potential weaknesses. The ®rst is that it may not have captured pulmonary complications which occurred acutely, resulting in death of the patient. These acute events may not have triggered radiology evaluation, and therefore would have been missed in this analysis. The authors of this study who provided the primary care for all patients do not recall any such catastrophic pulmonary event. Secondly, when analyzing the association of persistent pleural effusions and rejection, the authors chose not to control for potential confounding factors such as concurrent pneumonia and ascites. The majority of infectious agents found in this study are not commonly associated with pleural effusions, and ascites, although present in six patients, was minimal and often resolved despite a persistent pleural effusion. The ®nal weakness is the lack of laboratory data on the pleural¯uid samples. Leukocyte counts were the only values consistently available for review. Although it is likely that protein, glucose and bacterial cultures were obtained, these results were not consistently recorded in the patient's chart. Therefore, only limited interpretation of the persistent pleural effusion characteristics was possible.
Pneumonia developed in approximately one®fth of the study population. The patients suffered from several types of viral pneumonia, including one patient with RSV. A recent study revealed an incidence of RSV pneumonia of 3.4% in post-operative pediatric liver transplant recipients (6) . In that study, 13 of the 17 patients had nosocomial acquisition of RSV. This is an incidence that is four times greater than in our study population. The differences in incidence may be related to an RSV epidemic or infection control issues. Our center's approach to respiratory infections diagnosed prior to OLT is conservative. Patients awaiting OLT who develop respiratory symptoms during the winter months are tested for RSV prior to transplantation. If RSV infection is diagnosed, transplantation is deferred and strict infection control policies maintained. In addition, patients with active respiratory infection, i.e. fever, cough or bronchiolitis, are excluded from transplantation until resolution of symptoms.
The vast majority of transplant recipients who suffered from bacterial pneumonia recovered. The only aspergillus infection in this group was fatal. The infectious disease literature reveals that invasive aspergillus infections in immunocompromised hosts have a fatality rate of greater than 90% (7, 8) . The patient who died from this also suffered from toxic epidermal necrolysis, which has been associated with aspergillus in terminally ill patients.
An interesting ®nding during our search was the presence of pulmonary calci®cations. The etiology of this occurrence is speculative. Dystrophic calci®cation may occur in lung tissue damaged by infection or hemorrhage. Metastatic calci®cation may result from pro-longed hypercalcemia (9, 10) . Hypercalcemia leading to metastatic calci®cation may be secondary to renal failure or excessive administration of blood products peri-operatively. Our patients with calci®cations had multiple blood transfusions but none had demonstrated hypercalcemia. Another possible theory to explain pulmonary calci®cations is that calcium salts precipitate in the alkalotic environment produced by assisted ventilation (9) . One patient did have prolonged ventilation prior to the appearance of pulmonary calcium deposits. In this series, pulmonary calci®cations were an incidental ®nd-ing and did not compromise pulmonary function.
Over 10% of the patients in this study had an elevated right diaphragm on chest X-ray. Right hemidiaphragm paralysis has been studied previously in post-operative adult liver transplant recipients. McAlister et al. (11) performed transcutaneous phrenic nerve conduction studies and found that 79% of liver recipients had right phrenic nerve injury. Approximately half of these patients also had hemidiaphragm paralysis. In our retrospective study, the majority of patients with an elevated right hemidiaphragm or abnormal diaphragm motion post-operatively did not have substantial respiratory dysfunction. However, there were four patients who needed diaphragm plication because the paralysis was impeding ventilation. This occurred within 24 h after surgery in two patients and supports McAlister's ®ndings that the paralysis was secondary to a crush injury of the phrenic nerve. A prospective study of phrenic nerve and diaphragm function in peri-operative pediatric OLT patients is necessary to fully understand the mechanism of insult and the degree of respiratory compromise.
It has been the authors' experience that rapidly accumulating and persistent pleural effusions have been associated with the concurrent onset of mild to moderate liver transplant rejection. This association was found to be statistically signi®cant in this study. These effusions usually began near the end of the ®rst week posttransplant and preceded any liver enzyme elevation indications of rejection. The effusions also showed resolution simultaneous with treatment of the rejection. The cell types present in persistent pleural effusions associated with rejection were not statistically different from those without rejection. This may be due in part to the small sample size of cell counts (n = 22). Lymphocyte predominance was the trend in the patients with persistent pleural effusion and rejection. The presence of excess lymphocytes may be related to T-cell activation from allograft rejection. Large persistent pleural effusions beginning near the end of the ®rst post-operative week and requiring chest tubes should alert the physician to possible impending liver transplant rejection. Additional diagnostic studies should therefore be initiated in order to lessen morbidity.
